Neusoft signs subscription agreement with Aerotel Medical Systems

Neusoft Corporation ("Neusoft", 600718.SH), a leading IT solution and service provider in China, recently announced that its wholly-owned subsidiary Neusoft Europe Inc. ("Neusoft Europe") has signed a subscription agreement with Aerotel Medical Systems Ltd. ("Aerotel"), a leading global manufacturer of modular, mobile and home based telemedicine and telecare solutions based in Israel, under which Neusoft Europe will subscribe for 26915 shares of Aerotel with 1.77 million US Dollars to hold 30.77% of its outstanding shares. This transaction will enable Neusoft to obtain more resources and further accelerate its steps entering into the global healthcare service market.

Currently this transaction is subject to regulatory approvals in China.

With medical business as one of its major businesses, Neusoft has been engaged in medical equipment, medical IT solutions and healthcare services over the past 10 years and has become China's market leader in the industry. Meanwhile, the company has been actively expanding in the global market, and its medical equipment is exported to approximately 60 countries and regions across the globe. By integrating with Aerotel's leading expertise in healthcare service, Neusoft will greatly improve the overall competency of its existing healthcare service business, and quickly extend its advantages in China to Europe and the global market.

Aerotel, with more than a decade of rich experience in this industry, has been maintaining strong innovative technology capabilities and a widely-covered sales network with a client base in over 40 countries and regions around the globe. By partnering with Neusoft, Aerotel will gain more capital to support its R&D and business growth, and enhance the competitiveness of its products and services in the global market.

"We are delighted to establish a close strategic partnership with Aerotel," said Dr. Liu Jiren, Chairman & CEO of Neusoft Corporation. "Aerotel's excellent sales network, products and R&D talent will bring new growth momentum to Neusoft and enable us to enrich our healthcare service portfolio, strengthen the global delivery capacity, create more value to our customers, and significantly promote our business expansion in European and global healthcare markets."